| Robert J Mcclure, MD | |
|
1400 29th St S, Great Falls, MT 59405-5353 | |
| (406) 454-2171 | |
| (406) 771-3021 |
| Full Name | Robert J Mcclure |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology - Gynecology |
| Location | 1400 29th St S, Great Falls, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932100567 | NPI | - | NPPES |
| 0042926 | Medicaid | MT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VG0400X | Obstetrics & Gynecology - Gynecology | 4250 (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Robert J Mcclure, MD 1400 29th St S, Great Falls, MT 59405-5353 Ph: (406) 454-2171 | Robert J Mcclure, MD 1400 29th St S, Great Falls, MT 59405-5353 Ph: (406) 454-2171 |
News Archive
The investigational anticancer therapeutic abemaciclib, which targets CDK4 and CDK6, showed durable clinical activity when given as continuous single-agent therapy to patients with a variety of cancer types, including breast cancer, non-small cell lung cancer (NSCLC), glioblastoma, and melanoma, according to results from a phase I clinical trial.
The Harvard Clinical Research Institute (HCRI) announced today that the enrollment phase of the DAPT Study has been successfully completed. The DAPT Study is a four-year clinical trial investigating the duration of dual antiplatelet therapy (DAPT, the combination of aspirin and a thienopyridine/antiplatelet medication to reduce the risk of blood clots) following drug-eluting stent implantations.
Neurosurgeons and neuroradiologists at Cedars-Sinai Medical Center injected a biosynthetic "glue" to seal off a spinal fluid leak and restore a comatose patient to consciousness.
Sunshine Biopharma Inc. is pleased to announce that it has recently received notification that the United States Patent and Trademark Office has issued a "Notice of Allowance" for the patent application covering its lead anti-tumor compound, Adva-27a. The allowed claims protect Adva-27a and extensively cover various formulations, derivatives and cancer applications.
In the largest study of its kind, researchers from a consortium of 44 universities and research institutions in the United States, including Rush University Medical Center, identified four new genes linked to Alzheimer's disease. Each gene individually adds to the risk of having this common form of dementia later in life.
› Verified 9 days ago
Francis J Handwerk, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1400 29th St S, Great Falls, MT 59405 Phone: 406-454-2171 Fax: 406-771-3021 | |
Mr. Jeffery A Palen, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1401 25th St S, Great Falls, MT 59405 Phone: 406-731-8888 | |
Vicki L Chapman, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1400 29th St S, Ste 101, Great Falls, MT 59405 Phone: 406-761-7924 | |
Daren J Braget, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1400 29th St S, Suite 101, Great Falls, MT 59405 Phone: 406-761-7924 Fax: 406-761-7924 | |
Julie L Kuykendall, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1101 26th St S, Great Falls, MT 59405 Phone: 406-731-8888 Fax: 406-731-8876 | |
Julia C Middleton, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1400 29th St S Ste 101, Great Falls, MT 59405 Phone: 406-761-7924 | |
Sandra L Bailey, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1400 29th St S, Suite 101, Great Falls, MT 59405 Phone: 406-761-7924 Fax: 406-761-7945 |